Financials ChemoMetec A/S

Equities

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 06:12:51 2024-07-10 am EDT			5-day change	1st Jan Change
374.3 ^DKK	+1.27%		+6.36%	-3.40%

Jul. 02	ChemoMetec A/S Announces Preliminary Revenue for the Fourth Quarter and Full Year of 2024	CI
May. 27	Denmark's ChemoMetec Appoints New CFO	MT

Valuation

Fiscal Period: June	2021	2022	2023	2024	2025	2026
Capitalization ¹	14,679	13,174	8,110	6,432	-	-
Enterprise Value (EV) ¹	14,679	13,174	7,800	6,095	6,037	5,982
P/E ratio	166 x	82.6 x	45.4 x	49.9 x	41.3 x	35.2 x
Yield	-	0.53%	-	1.17%	1.44%	1.53%
Capitalization / Revenue	-	30.8 x	18.3 x	15.8 x	13.8 x	12 x
EV / Revenue	-	30.8 x	17.6 x	15 x	13 x	11.2 x
EV / EBITDA	-	59.1 x	31.1 x	32.4 x	27.4 x	23.2 x
EV / FCF	-	-	68.8 x	62 x	45.1 x	40.1 x
FCF Yield	-	-	1.45%	1.61%	2.22%	2.5%
Price to Book	-	-	15.2 x	10.9 x	9.57 x	8.43 x
Nbr of stocks (in thousands)	17,402	17,402	17,402	17,402	-	-
Reference price ²	843.5	757.0	466.0	369.6	369.6	369.6
Announcement Date	9/17/21	9/15/22	9/13/23	-	-	-

¹DKK in Million²DKK

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June	2021	2022	2023	2024	2025	2026
Net sales ¹	-	427.2	442.3	407.4	465.3	534.8
EBITDA ¹	-	222.9	251	188.2	220	257.8
EBIT ¹	-	202.9	230.6	168.9	198.4	233.8
Operating Margin	-	47.48%	52.13%	41.47%	42.64%	43.71%
Earnings before Tax (EBT) ¹	-	-	230.4	170.6	199.4	234.2
Net income ¹	88.35	159.5	178.7	128.8	155.6	183
Net margin	-	37.34%	40.4%	31.61%	33.43%	34.22%
EPS ²	5.080	9.160	10.27	7.407	8.942	10.51
Free Cash Flow ¹	-	-	113.3	98.33	134	149.3
FCF margin	-	-	25.62%	24.14%	28.8%	27.92%
FCF Conversion (EBITDA)	-	-	45.15%	52.25%	60.92%	57.92%
FCF Conversion (Net income)	-	-	63.43%	76.37%	86.13%	81.61%
Dividend per Share ²	-	4.000	-	4.333	5.333	5.667
Announcement Date	9/17/21	9/15/22	9/13/23	-	-	-

¹DKK in Million²DKK

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June	2024 Q2	2024 S1	2024 Q3	2024 Q4	2024 S2	2025 S1	2025 S2
Net sales ¹	108.1	199.3	98.9	107	208	220	234
EBITDA ¹	51.6	93.1	43.1	49.2	94	102	104
EBIT ¹	-	84.65	43.5	49.2	85	93	94
Operating Margin	-	42.47%	43.98%	45.98%	40.87%	42.27%	40.17%
Earnings before Tax (EBT)	-	89.02	-	-	88	95	96
Net income ¹	-	70.56	43.5	49.2	69	74	75
Net margin	-	35.4%	43.98%	45.98%	33.17%	33.64%	32.05%
EPS ²	-	4.050	2.500	2.830	3.960	4.250	4.320
Dividend per Share	-	-	-	-	-	-	-
Announcement Date	2/5/24	2/5/24	5/8/24	-	-	-	-

¹DKK in Million²DKK

Estimates

Balance Sheet Analysis

Fiscal Period: June	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-	-	-	-	-
Net Cash position ¹	-	-	309	337	395	450
Leverage (Debt/EBITDA)	-	-	-	-	-	-
Free Cash Flow ¹	-	-	113	98.3	134	149
ROE (net income / shareholders' equity)	-	51.4%	39.5%	22.9%	24.9%	26.3%
ROA (Net income/ Total Assets)	-	-	-	18.6%	18.9%	18.7%
Assets ¹	-	-	-	692.3	823.2	978.6
Book Value Per Share ²	-	-	30.60	34.00	38.60	43.80
Cash Flow per Share ²	-	10.20	8.860	8.000	10.40	12.20
Capex ¹	-	-	40.8	48	45.4	52.4
Capex / Sales	-	-	9.23%	11.78%	9.75%	9.79%
Announcement Date	9/17/21	9/15/22	9/13/23	-	-	-

¹DKK in Million²DKK

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for ChemoMetec A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

369.6 DKK

Average target price

437.5 DKK

Spread / Average Target

+18.37%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
CHEMOMETEC A/S	-4.02%	932M
SHOCKWAVE MEDICAL	+75.69%	12.57B
PENUMBRA, INC.	-29.24%	6.9B
MASIMO CORPORATION	-8.77%	5.69B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+5.81%	5.04B
GETINGE AB	-17.25%	4.69B
APT MEDICAL INC.	+17.07%	4.18B
ASAHI INTECC CO., LTD.	-18.25%	3.86B
INARI MEDICAL, INC.	-21.23%	2.97B
SKAN GROUP AG	-1.73%	1.99B

Medical Equipment